WEHI-345 is a compound that targets RIP kinases and is a critical regulator of various cellular processes, including apoptosis, necroptosis, and inflammation.
Molecular Weight
401.46
Molecular Formula
C22H23N7O
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
WEHI-345 can be employed to research the roles of RIPK1 inhibition in cellular signaling and inflammation.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
